Patents
Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408)
09/2010
09/14/2010US7795287 Therapeutic substituted hydantoins and related compounds
09/14/2010US7795265 such as 3-(4-{[1-(3-ethoxyphenyl)-2-(4-methylphenyl)-1H-imidazol-4-yl]carbonyl}-1-piperazinyl)-1-naphthoic acid, used for the treatment of obesity or diabetes
09/14/2010US7794945 Conjugates between a minor groove binding the trimer of 1,2-dihydro- (3H)-pyrrolo(3,3-e)indole-7-carboxylate and an oligonucleotide and forms stable hybrids with complementary target sequence
09/14/2010CA2422805C Retinoids for the treatment of emphysema
09/14/2010CA2394276C Serine protease inhibitors
09/14/2010CA2388979C Treatment or prevention of hypotension and shock with use of an imidazole derivative
09/14/2010CA2356871C Synthesis of histamine dihydrochloride
09/10/2010WO2010100606A1 Novel phenyl imidazoles and phenyl triazoles as gamma-secretase modulators
09/10/2010CA2751534A1 Novel phenyl imidazoles and phenyl triazoles as gamma-secretase modulators
09/09/2010US20100228035 Functionalized Ionic Liquids, and Methods of Use Thereof
09/09/2010US20100228031 Catalysts for alkene isomerization and conjugating double bonds in polyunsaturated fats and oils
09/09/2010US20100227898 Novel microbiocides
09/09/2010US20100227855 Helix 12 directed non-steroidal antiandrogens
09/09/2010US20100226969 Compounds for inhibiting protein aggregation, and methods for making and using them
09/09/2010US20100226882 Linked diimidazole antivirals
09/08/2010EP2226322A1 Imidazole carbonyl compound
09/08/2010EP2225245A2 N-phenyl-imidazoý1,2-a¨pyridine-2-carboxamide compounds, preparation thereof and therapeutic application thereof
09/08/2010EP2225243A2 Derivatives of n-heterocyclic-6-heterocyclic-imidazoýl,2- a¨pyridine-2-carboxamides, preparation thereof and therapeutic application thereof
09/08/2010EP2225242A2 Derivatives of n-heterocyclic-imidazoý1,2-a¨pyridine-2-carboxamides, preparation thereof and therapeutic application thereof
09/08/2010EP2225241A2 Derivatives of n-phenyl-imidazoý1,2-a¨pyridine-2-carboxamides, preparation thereof and therapeutic application thereof
09/08/2010EP2225240A2 Derivatives of 6-heterocyclic-imidazoýl,2-a¨pyrroine-2-carboxamides, preparation thereof and therapeutic application thereof
09/08/2010EP2225209A1 Process for the preparation of 5-(2-ethyl-dihydro-1h-inden-2-yl)-1h-imidazole and salts thereof
09/08/2010EP2225208A1 Permanently free-flowing ethylene urea
09/08/2010CN101827840A Imidazolidine-2,4-dione (hydantoin) derivatives useful as npy y2 receptor modulators
09/08/2010CN101827826A 4-phenyl-5-oxo-imidazole derivatives, pharmaceutical compositions and uses therof
09/08/2010CN101337939B Alkaline ionic liquid, method for preparing same and applications
09/07/2010US7790762 A heteroaryl bonded to a phenol through a ketone and a double bond; cystic fibrosis
09/07/2010US7790719 used for the treatment of cachexia and other weight loss disorders, such as those resulting from cancer, HIV, old age and anorexia nervosa
09/02/2010WO2010099518A2 Method for manufacture of 2-oxoimidazolidines
09/02/2010WO2010097640A1 Biodiesel containing non-phenolic additives and thereby possessing enhanced oxidative stability and low acid number
09/02/2010WO2010097467A1 N-phenylacetamide derivatives, which inhibit the enzyme soat-1 and pharmaceutical and cosmetic compositions containing them
09/02/2010WO2010097465A1 Dioxo-imidazolidine derivatives, which inhibit the enzyme soat-1, and pharmaceutical and cosmetic compositions containing them
09/02/2010WO2010097464A1 Novel n-phenylacetamide derivatives, which inhibit the enzyme soat-1, and pharmaceutical and cosmetic compositions containing them
09/02/2010WO2010097412A1 Ionic liquid solvents
09/02/2010WO2010097372A1 Compounds as bradykinin b1 antagonists
09/02/2010US20100222598 PROCESS FOR PREPARING HETEROAROMATIC RING COMPOUND HAVING N-Rf GROUP
09/02/2010US20100222580 Process For The Preparation Of Onium Alkylsulfates Having A Low Halide Content
09/02/2010US20100222400 F1F0-ATPase Inhibitors and Related Methods
09/02/2010US20100222393 Muscarinic receptor antagonists
09/02/2010US20100222358 Octahydro-pyrrolo[3,4-b]pyrrole derivatives
09/02/2010US20100222326 New Heterocyclic Derivatives Useful For The Treatment of CNS Disorders
09/02/2010US20100221182 Ligands for imaging cardiac innervation
09/02/2010CA2759126A1 New compounds
09/02/2010CA2751328A1 Novel dioxo-imidazolidine derivatives, which inhibit the enzyme soat-1, and pharmaceutical and cosmetic compositions containing them
09/02/2010CA2751327A1 Novel n-phenylacetamide derivatives, which inhibit the enzyme soat-1, and pharmaceutical and cosmetic compositions containing them
09/02/2010CA2751296A1 Novel n-phenylacetamide derivatives, which inhibit the enzyme soat-1, and pharmaceutical and cosmetic compositions containing them
09/01/2010EP2223915A1 Ionic liquid solvents
09/01/2010EP2222644A2 Method for producing precursors for l-2-[18f]fluorophenylalanine and 6-[18f]fluoro-l--meta-tyrosine and the alpha -methylated derivatives thereof, precursor, and method for producing l-2-[18f]fluorophenylalanine and 6-[18f]fluoro-l-meta-tyrosine and the alpha-methylated derivatives from the precursor
09/01/2010EP2222638A2 Biaryl pde4 inhibitors for treating inflammation
09/01/2010EP1979322B1 Cyclohexyl sulfonamide derivatives having h3 receptor activity
09/01/2010EP1379508B1 N-(aryl)-2-arylethenesulfonamides and therapeutic uses thereof
09/01/2010EP1028942B1 Dipeptide nitriles
09/01/2010CN101821241A Gamma secretase modulators
09/01/2010CN101817787A Androgen receptor antagonist for resisting prostate cancer
09/01/2010CN101817786A Method for preparing (S)-ornidazole
09/01/2010CN101817785A Ionic liquids based on imidazolium salts incorporating a nitrile functionality
09/01/2010CN101817764A Preparation method of chain-like urea derivatives, cyclic urea derivatives and oxazolidinone
09/01/2010CN101816658A HIV inhibiting pyrimidines derivatives
09/01/2010CN101343252B Method for separating 2,4-diphenyl oxazole and 2,4-diphenyl imidazole mixture
08/2010
08/31/2010US7786301 Process for preparing xanthine phosphodiesterase V inhibitors and precursors thereof
08/31/2010US7786158 Compounds as opioid receptor modulators
08/31/2010US7786155 such as N-(1,2-Dimethyl-propyl)-4-[2-(2-methyl-5-oxo-4,4-diphenyl-4,5-dihydro-imidazol-1-yl)-acetyl]-benzamide, used as neuropeptide Y receptor antagonists, useful in treating nervous system disorders, sleep disorders, cardiovascular disorders; metabolic disorders, inovulation and infertility
08/31/2010US7786122 use to treat Alzheimer's Disease; (2R)-2-[N-(4-Chlorobenzenesulfonyl)-N-(4-methoxybenzyl)amino]-4-methylpentanoic acid amide for example
08/26/2010WO2010096722A1 3-oxo-2, 3-dihydro- [1,2, 4] triazolo [4, 3-a]pyridines as soluble epoxide hydrolase (seh) inhibitors
08/26/2010WO2010096584A1 Coupled recognition/detection system for in vivo and in vitro use
08/26/2010WO2010094640A1 Distillation of ionic liquids using an auxiliary distillation agent
08/26/2010WO2010009402A3 Nilotinib intermediates and preparation thereof
08/26/2010WO2009150547A3 2-pyridyl substituted imidazoles as alk4 and/or alk4 inhibitors
08/26/2010US20100217010 Process for preparing ionic liquids by anion exchange
08/26/2010US20100216855 Imidazaolone derivatives,preparation thereof and biological use of same
08/26/2010US20100216854 1,3 and 1,3,5 substituted imidazoles as antihypertensives
08/26/2010US20100216827 Aryl gpr120 receptor agonists and uses thereof
08/26/2010US20100216772 Novel Phenantridine Analogues and Uses Thereof
08/26/2010DE102010001957A1 Distillation of a mixture containing an ionic liquid and a mixture of metal salt, where the cation of the liquid contains a heterocyclic ring system with a nitrogen atom and all nitrogen atoms of the ring system have organic groups
08/25/2010EP2220050A2 Diarylhydantoin compounds as androgen receptor modulators
08/25/2010EP2220049A2 Method for producing precursors for l-3,4-dihydroxy-6-[18f]fluorophenylalanine and 2-[18f]fluoro-l-tyrosine and the alpha -methylated derivatives thereof, precursor, and method for producing l-3,4 dihydroxy-6-[18f]fluorophenylalanine and 2-[18f]fluoro-l-tyrosine and the alpha-methylated derivatives from the precursor
08/25/2010EP2220030A2 4- (p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases
08/25/2010EP1620082B9 Medical use of inhibitors of glutaminyl and glutamate cyclases for treating alzheimer's disease and down syndrome
08/25/2010EP1366016B1 Process for the preparation of arylethanoldiamines useful as agonists of the beta-3-adrenoceptor
08/25/2010CN101812020A Synthesis method of tetra-substituted imidazole medicament molecule and analogs thereof
08/25/2010CN101810608A Anti-tumor small molecule compound targeting at human phosphatidylethanolamine-bindingprotein-4
08/24/2010US7781597 Efficiency; 5-94-methyl-1H-imidazol-1-yl)benzamine as chemical intermediate for pyrimidinylaminobenzamide
08/24/2010US7781461 Neuropeptide Y receptor antagonists comprising 4-(tert-butylsulfonylamino)-N-[5-(trifluoromethyl)pyridin-2-yl]cyclohexane-1-carboxamide and a pharmaceutically acceptable carrier, used for the treatment of obesity and as anorexigenic agents
08/24/2010US7781383 Lubricant for fluid dynamic bearing, spindle motor equipped therewith and magnetic disk unit
08/24/2010US7781183 Inhibition of anthrax lethal factor protease
08/24/2010CA2423103C N-acylsulfonamide apoptosis promoters
08/19/2010WO2010093910A1 4-(1-(3-(hydroxymethyl)-2-methylphenyl)ethyl)-1h-imidazole-2(3h)-thione
08/19/2010WO2010093845A1 Triazole and imidazole derivatives for use as tgr5 agonists in the treatment of diabetes and obesity
08/19/2010WO2010092180A1 Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy
08/19/2010WO2010092043A1 Phenoxy acetic acid derivatives
08/19/2010WO2010047774A3 Inhibitors of mycobacterium tuberculosis malate synthase, methods of marking and uses thereof
08/19/2010US20100210855 Sulfonic acid salt compound of 4-carbamoyl-5-hydroxy-imidazole derivative
08/19/2010US20100210699 Imidazolidine derivatives, uses therefor, preparation thereof and compositions comprising such
08/19/2010US20100210696 5-membered heterocyclic compound
08/19/2010US20100210665 Diarylhydantoin compounds
08/19/2010CA2752156A1 4-(1-(3-(hydroxymethyl)-2-methylphenyl)ethyl)-1h-imidazole-2(3h)-thione
08/19/2010CA2751260A1 Phenoxy acetic acid derivatives
08/19/2010CA2750793A1 Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy
08/18/2010EP2217574A1 Method for producing ionic liquids by anion exchange
08/18/2010EP2217573A1 Treating and preventing viral infections
1 ... 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 ... 345